Financials
- Market Capitalization 2.01 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.64
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1966 | VCEL Vericel Corporation - Common Stock | 40.95 USD | -0.56% | -5.23% | -10.94% | +12.65% | 2.10 B USD | ||
| 1996 | ZYME Zymeworks Inc. - Common Stock | 28.46 USD | +0.67% | +2.23% | +29.66% | +60.43% | 2.02 B USD | ||
| 2006 | STOK Stoke Therapeutics, Inc. - Common Stock | 30.96 USD | -2.09% | -4.24% | +8.18% | +56.44% | 2.00 B USD | ||
| 2009 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 33.24 USD | -0.24% | +1.00% | +7.99% | -23.39% | 1.98 B USD |